BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16498276)

  • 1. [Psychosocial factors and visceral hypersensitivity in irritable bowel syndrome].
    Lee OY
    Korean J Gastroenterol; 2006 Feb; 47(2):111-9. PubMed ID: 16498276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms.
    Deiteren A; de Wit A; van der Linden L; De Man JG; Pelckmans PA; De Winter BY
    Acta Gastroenterol Belg; 2016 Mar; 79(1):29-38. PubMed ID: 26852761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ
    Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome.
    Delvaux M
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):747-71. PubMed ID: 15324712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of psychological stress on irritable bowel syndrome.
    Qin HY; Cheng CW; Tang XD; Bian ZX
    World J Gastroenterol; 2014 Oct; 20(39):14126-31. PubMed ID: 25339801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress.
    O'Mahony SM; Clarke G; Dinan TG; Cryan JF
    Handb Exp Pharmacol; 2017; 239():219-246. PubMed ID: 28233180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.
    Crowell MD; Harris L; Jones MP; Chang L
    Curr Gastroenterol Rep; 2005 Aug; 7(4):272-9. PubMed ID: 16042910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of the non-pharmacological treatment of irritable bowel syndrome.
    Eriksson EM; Andrén KI; Kurlberg GK; Eriksson HT
    World J Gastroenterol; 2015 Oct; 21(40):11439-49. PubMed ID: 26523108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.
    Simrén M; Törnblom H; Palsson OS; Van Oudenhove L; Whitehead WE; Tack J
    Gastroenterology; 2019 Aug; 157(2):391-402.e2. PubMed ID: 31022401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of enteric neural function in irritable bowel syndrome.
    O'Malley D
    World J Gastroenterol; 2015 Jun; 21(24):7362-6. PubMed ID: 26139983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient habituation to repeated rectal distensions in irritable bowel syndrome patients with visceral hypersensitivity.
    Lowén MB; Mayer E; Tillisch K; Labus J; Naliboff B; Lundberg P; Thorell LH; Ström M; Engström M; Walter S
    Neurogastroenterol Motil; 2015 May; 27(5):646-55. PubMed ID: 25777251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial determinants of irritable bowel syndrome.
    Surdea-Blaga T; Băban A; Dumitrascu DL
    World J Gastroenterol; 2012 Feb; 18(7):616-26. PubMed ID: 22363132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Irritable bowel syndrome: from the gut to the brain-gut].
    Ducrotté P
    Gastroenterol Clin Biol; 2009; 33(8-9):703-12. PubMed ID: 19682813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?
    Camilleri M
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S46-8. PubMed ID: 19300123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional findings in irritable bowel syndrome.
    Posserud I; Ersryd A; Simrén M
    World J Gastroenterol; 2006 May; 12(18):2830-8. PubMed ID: 16718806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study.
    Elsenbruch S; Rosenberger C; Enck P; Forsting M; Schedlowski M; Gizewski ER
    Gut; 2010 Apr; 59(4):489-95. PubMed ID: 19651629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?
    O'Malley D; Quigley EM; Dinan TG; Cryan JF
    Brain Behav Immun; 2011 Oct; 25(7):1333-41. PubMed ID: 21536124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.